Table of Contents Author Guidelines Submit a Manuscript
Volume 7, Pages 1082-1089
Research Article

Is There Any Point in a Corticosteroid Treatment of Intermittent Asthma?

1The Clinic for Lung Diseases and TBC, University Hospital, Niš, Serbia
2The Institute for Lung Diseases, University Hospital, Belgrade, Serbia

Received 11 February 2007; Revised 8 May 2007; Accepted 11 May 2007

Academic Editor: Joav Merrick

Copyright © 2007 Ivana Stankovic et al.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • O. Polat, T. Aytug, M. Paranthaman, K. Kim, Y. Zhang, J. R. Thompson, D. K. Christen, X. Xiong, and V. Selvamanickam, “Direct growth of LaMnO3 cap buffer layers on ion-beam-assisted deposition MgO for simplified template-based YBa2Cu3O7-delta-coated conductors,” Journal Of Materials Research, vol. 23, no. 11, pp. 3021–3028, 2008. View at Publisher · View at Google Scholar
  • Louis-Philippe Boulet, Helene Turcotte, Philippe Prince, Catherine Lemiere, Ronald Olivenstein, Catherine Laprise, Pierre Larivee, Paul Begin, and Michel Laviolette, “Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma,” Respiratory Medicine, vol. 103, no. 10, pp. 1554–1563, 2009. View at Publisher · View at Google Scholar
  • J Mark Fitzgerald, and Neal Shahidi, “Current recommendations for the treatment of mild asthma,” Journal of Asthma and Allergy, vol. 3, pp. 169–176, 2010. View at Publisher · View at Google Scholar
  • Wei Du, Ling Zhou, Guochao Shi, Yingmeng Ni, Yuanyuan Yu, and Fang Wu, “Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis,” Experimental and Therapeutic Medicine, vol. 14, no. 2, pp. 1594–1608, 2017. View at Publisher · View at Google Scholar